BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 26127030)

  • 21. Evaluating radiotherapy treatment delay using Failure Mode and Effects Analysis (FMEA).
    Xu Z; Lee S; Albani D; Dobbins D; Ellis RJ; Biswas T; Machtay M; Podder TK
    Radiother Oncol; 2019 Aug; 137():102-109. PubMed ID: 31082631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-phase failure modes and effects analysis for low dose bilateral whole lung irradiation of COVID-19 positive patients requiring respiratory ventilation.
    Swanson AE; DiCostanzo DJ; Gupta N; Hintenlang K; Chakravarti A; Cetnar AJ
    J Appl Clin Med Phys; 2024 Apr; 25(4):e14261. PubMed ID: 38194600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure modes and effects analysis for surface-guided DIBH breast radiotherapy.
    Bright M; Foster RD; Hampton CJ; Ruiz J; Moeller B
    J Appl Clin Med Phys; 2022 Apr; 23(4):e13541. PubMed ID: 35112445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of safety in a radiation oncology setting using failure mode and effects analysis.
    Ford EC; Gaudette R; Myers L; Vanderver B; Engineer L; Zellars R; Song DY; Wong J; Deweese TL
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):852-8. PubMed ID: 19409731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A failure modes and effects analysis quality management framework for image-guided small animal irradiators: A change in paradigm for radiation biology.
    Poirier Y; Johnstone CD; Anvari A; Brodin NP; Santos MD; Bazalova-Carter M; Sawant A
    Med Phys; 2020 Apr; 47(4):2013-2022. PubMed ID: 31986221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of failure modes and effect analysis for routine risk assessment of lung radiotherapy at a UK center.
    Gilmore MDF; Rowbottom CG
    J Appl Clin Med Phys; 2021 May; 22(5):36-47. PubMed ID: 33835698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MO-D-BRB-07: Failure-Mode and Effects Analysis Study for CyberKnife Stereotactic Radiosurgery.
    Dieterich S; Ford E; Halasz C
    Med Phys; 2012 Jun; 39(6Part21):3867. PubMed ID: 28518281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitigation of Intensity Modulated Radiation Therapy and Stereotactic Body Radiation Therapy Treatment Planning Errors on the Novel RefleXion X1 System Using Failure Mode and Effect Analysis Within Six Sigma Framework.
    Simiele E; Han B; Skinner L; Pham D; Lewis J; Gensheimer M; Vitzthum L; Chang D; Surucu M; Kovalchuk N
    Adv Radiat Oncol; 2023; 8(5):101186. PubMed ID: 37035034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using failure mode and effects analysis (FMEA) to generate an initial plan check checklist for improved safety in radiation treatment.
    Rassiah P; Su FF; Huang YJ; Spitznagel D; Sarkar V; Szegedi MW; Zhao H; Paxton AB; Nelson G; Salter BJ
    J Appl Clin Med Phys; 2020 Aug; 21(8):83-91. PubMed ID: 32583912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A streamlined failure mode and effects analysis.
    Ford EC; Smith K; Terezakis S; Croog V; Gollamudi S; Gage I; Keck J; DeWeese T; Sibley G
    Med Phys; 2014 Jun; 41(6):061709. PubMed ID: 24877804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of two prospective risk analysis methods: Traditional FMEA and a modified healthcare FMEA.
    Rah JE; Manger RP; Yock AD; Kim GY
    Med Phys; 2016 Dec; 43(12):6347. PubMed ID: 27908165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of failure mode and effects analysis to intraoperative radiation therapy using mobile electron linear accelerators.
    Ciocca M; Cantone MC; Veronese I; Cattani F; Pedroli G; Molinelli S; Vitolo V; Orecchia R
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e305-11. PubMed ID: 21708432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of failure mode effect analysis (FMEA) to improve medication management process.
    Jain K
    Int J Health Care Qual Assur; 2017 Mar; 30(2):175-186. PubMed ID: 28256927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure mode and effects analysis outputs: are they valid?
    Shebl NA; Franklin BD; Barber N
    BMC Health Serv Res; 2012 Jun; 12():150. PubMed ID: 22682433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of failure mode and effects analysis to treatment planning in scanned proton beam radiotherapy.
    Cantone MC; Ciocca M; Dionisi F; Fossati P; Lorentini S; Krengli M; Molinelli S; Orecchia R; Schwarz M; Veronese I; Vitolo V
    Radiat Oncol; 2013 May; 8():127. PubMed ID: 23705626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure modes and effects analysis of pediatric I-131 MIBG therapy: Program design and potential pitfalls.
    Maughan NM; Garcia-Ramirez JL; Huang FS; Willis DN; Iravani A; Amurao M; Luechtefeld D; Mhlanga JC; Perkins SM; Zoberi JE
    Pediatr Blood Cancer; 2022 Dec; 69(12):e29996. PubMed ID: 36102748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure mode and effects analysis (FMEA) to enhance the safety and efficiency of Gamma Knife radiosurgery.
    Warnick RE; Lusk AR; Thaman JJ; Levick EH; Seitz AD
    J Radiosurg SBRT; 2020; 7(2):115-125. PubMed ID: 33282465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using Failure Mode and Effects Analysis to Evaluate Risk in the Clinical Adoption of Automated Contouring and Treatment Planning Tools.
    Nealon KA; Balter PA; Douglas RJ; Fullen DK; Nitsch PL; Olanrewaju AM; Soliman M; Court LE
    Pract Radiat Oncol; 2022; 12(4):e344-e353. PubMed ID: 35305941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A failure modes and effects analysis study for gynecologic high-dose-rate brachytherapy.
    Mayadev J; Dieterich S; Harse R; Lentz S; Mathai M; Boddu S; Kern M; Courquin J; Stern RL
    Brachytherapy; 2015; 14(6):866-75. PubMed ID: 26204807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consistency of FMEA used in the validation of analytical procedures.
    Oldenhof MT; van Leeuwen JF; Nauta MJ; de Kaste D; Odekerken-Rombouts YM; Vredenbregt MJ; Weda M; Barends DM
    J Pharm Biomed Anal; 2011 Feb; 54(3):592-5. PubMed ID: 20970277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.